Vancomycin has become a first-line drug for the treatment of catheter-associated infections since an appreciable number of these complications yield coagulase-negative and -positive staphylococci with Dis ., in press). Briefly, a 6-month-old infant with short-gut syndrome received parenteral nutrition through a Broviac central venous catheter and small volumes of hydrolyzed infant formula (Pregestimil; Mead Johnson, Evansville, Ind.) through a gastrostomy tube. During therapy with vancomycin for catheter-associated Staphylococcus epidermidis bacteremia, the patient developed fever, and on several occasions blood drawn through the catheter as well as a peripheral vein yielded more than 200 CFU of a vancomycinresistant, gram-positive streptococcus per ml. Treatment with penicillin and tobramycin resulted in clinical resolution and negative blood cultures. During the following 6-month period, the child continued to receive nutrition parenterally and was fed through a gastrostomy tube without a recurrence of the infection.
In this report we summarize our efforts to establish the actual identity of this vancomycin-resistant Streptococcuslike bacterium and to understand its response to antibiotic agents. In addition, we report our preliminary findings of an approach that we used to separate Leuconostoc-like isolates from similarly appearing and reacting bacteria.
MATERIALS AND METHODS
Isolation and identification. The organism was recovered from blood by using a blood culture system (1.5 Microbial Tube; E. I. du Pont de Nemours & Co., Inc., Wilmington, Del.) and from the site of the gastrostomy tube insertion. Samples from these sites were plated onto 5% sheep blood agar (BBL Microbiology Systems, Cockeysville, Md.) and * Corresponding author.
enriched chocolate agar (BBL) and inoculated into boiled beef liver broth (13) . A similar bacterium was recovered from the formula that was intended for the gastrostomy tube feeding. Colonial morphology, especially polysaccharide production, was assessed on mitis salivarius agar (Difco Laboratories, Detroit, Mich.). Carbohydrate fermentation was tested by using cystine Trypticase agar base (BBL) with the following carbohydrates: trehalose, sorbitol, salicin, inulin, sucrose, glucose, mannose, raffinose, lactose, arabinose, glycerol, xylose, melibiose, fructose, pyruvate (utilization), and starch. Fermentation reactions were further assessed with the API Rapid CH system (API 50; Analytab Products, Plainview, N.Y.). Growth in broth containing 3, 4, and 6.5% NaCl and 10 and 40% bile was determined as directed in the Manual of Clinical Microbiology (8) . End product analysis for ethanol and lactate was done by gasliquid chromatography after growth in a special medium described by Garvie (11) , with the following composition per liter: glucose, 10 g; peptone (Trypticase; BBL), 7.5 g; yeast extract (BBL), 2.5 g; KH2PO4, 2.5 g; MgSO4 7H20, 2 g; MnSO4 4H20, 0.05 g; ammonium citrate, 1.0 g; sodium acetate, 2.5 g; Tween 80, 1.0 g; tomato juice, 100 ml (pH 6.5). Carbon dioxide production was assessed in a medium with glucose as the sole carbohydrate, as described by Gibson and Abdel-Malek (12) , with the following composition per liter: glucose, 50 g; nutrient gelatin (BBL), 150 g; K2HPO4, 2 g; yeast extract (BBL), 5.0 g; tomato juice, 100 ml (pH 7.0). After tubes containing 10 ml of this broth were autoclaved and cooled, they were inoculated heavily, and 2 ml of 2% melted agar was added as an overlay to capture gas liberated during fermentation. Tubes were then incubated at 35°C and observed for up to 4 weeks. Ammonia production from arginine was determined as described by Niven et al. (16) Colony counts to determine the CFU per milliliter were performed by the spread plate technique on 5% sheep blood agar plates (14) .
Response to antibiotics. 1-Lactamase production was determined by using nitrocefin-impregnated disks (BBL). Antibiotic susceptibility was examined by disk diffusion on sheep blood agar plates and by determination of MICs by using broth microdilution trays (Sensititre; GIBCO Laboratories, Lawrence, Mass.) (3), accompanied by use of appropriate controls. MBCs of penicillin were determined by the broth macrodilution method by using the medium described by Garvie (11) The response of leuconostocs to penicillin was examined further by inoculating 10 ml of the medium described by Garvie (11) containing 64 ,ug of penicillin per ml with 1.0 ml of the bacterium at a 0. Leuconostoc mesenteroides. The bacteria from the prepared formula, however, fitted the reactions of Leuconostoc lactis. No ,-lactamase activity was detected in the Leuconostoc isolates; MICs of penicillin were 1 ,ug/ml, and MBCs were greater than 64 ,ug/ml.
The API 50 panels confirmed the identifications of the two Leuconostoc spp. (4). Gas-liquid chromatographic analysis of the leuconostocs grown in the broth described by Garvie (11) indicated that ethanol and lactate were produced. The lactate was designated as D-(-)-lactate after it failed to react with the appropriate L-(+)-lactic dehydrogenase. All leuconostocs isolated from both sources produced C02 under the conditions described by Gibson and Abdel-Malek (12), but failed to produce ammonia from arginine as described by Niven et al. (16) ; these examinations have been advocated by Garvie (10, 11) for the identification of Leuconostoc spp.
Results of the studies with the AN-Ident enzyme system are presented in C Tested on mitis salivarius agar (Difco), which lacks the diammonium citrate that was in the medium described by Garvie (11 The same inoculum density was used for all experimental vessels. When penicillin was present at 64 ,ug/ml, analysis at 5 h yielded 3.2 x 105 CFU/ml, at 24 h there were 3.3 x 105 CFU/ml, and at 48 h there were 4.6 x 103 CFU/ml. Following the addition of P-lactamase after 5 h of exposure to penicillin, cultures of leuconostocs yielded 2.9 x 1010 CFU/ml after 24 h and 1.9 x 109 CFU/ml after 48 h. The addition of ,-lactamase after 24 h of exposure to penicillin resulted in 5.3 x 109 CFU/ml at 48 h, i.e., 24 h following the addition of the enzyme. Staphylococcus aureus ATCC 25913 served as an additional control. Penicillinase was added after 24 h of exposure to the antibiotics; no CFU were recovered in an effort to assess the survivors. The broth became turbid with Staphylococcus aureus after further incubation, however, indicating that there were survivors at a level of less than 0.01%. The leuconostocs and staphylococci did not produce detectable P-lactamase.
DISCUSSION
The organisms isolated from the patient described in this study were facultatively anaerobic, catalase-negative, grampositive cocci which produced alpha-hemolysis on sheep blood and failed to grow on 6.5% NaCl. Therefore, they were considered viridans group streptococci. Since highlevel vancomycin resistance is considered very unusual, if not unacceptable, for streptococci (19), we continued to study the organism further. Vancomycin-resistant, grampositive cocci may be Leuconostoc spp. We followed the guidelines suggested by Garvie (9-11) and identified our isolates as Leuconostoc spp. by performing examinations that separate this genus from streptococci, certain lactobacilli, and pediococci (Table 3) . The key reactions which differentiate Leuconostoc spp. from streptococci (in addition to vancomycin resistance) are gas production during glucose fermentation and the failure of Leuconostoc spp. to hydrolyze arginine with the production of ammonia, although certain streptococci also do not hydrolyze this amino acid. Streptococcal microscopic appearance and biochemical activity separate Leuconostoc spp. from Pediococcus spp. Microscopic morphology also serves to differentiate Leuconostoc spp. from most Lactobacillus spp. Leuconostoc spp. exist as round, elongate or egg-shaped, gram-positive cocci in chains that may be difficult to separate from certain heterofermentative lactobacilli that share similar environments and physiological and biochemical attributes. Numerical taxonomy (4) confirms this close relationship between Leuconostoc spp. and heterofermentative lactobacilli. Both groups lack hexose diphosphate aldolase, thus forcing glucose utilization via the phosphoketolase pathway (15) . However, the heterofermentative lactobacilli may also employ the pentose phosphate cycle, converting glyceraldehyde-3-phosphate to pyruvate and lactate. The lactate formed by Leuconostoc spp. is exclusively D-(-)-lactate, while the heterofermentative lactobacilli produce DL-lactate. The inability of L-(+)-lactic dehydrogenase to recognize the lactate produced by the Leuconostoc spp. that were isolated is strong supportive evidence that the lactate produced by these bacteria is D-(-)-lactate and that they are indeed members of the genus Leuconostoc. The fact that it is difficult to separate all Leuconostoc spp. from Lactobacillus confusus, and especially Lactobacillus viridescens, which has been emphasized by Garvie (10, 11) , was considered for the isolates examined in this study. The microscopic appearance and the usual production of ammonia from arginine by Lactobacillus confusus, coupled with the D-(-)-lactate found in the supernatants of the isolates, make it unlikely that this bacterium should be considered. Lactobacillus viridescens, which is the most likely candidate for obfuscating Leuconostoc recognition (11) because of its coccoid appearance, was ruled out on the basis of D-(-)-lactate production, results of several fermentation reactions, and the inability to hydrolyze esculin. Finally, although available information is limited, in a previous study (1) 89% of 37 lactobacilli were susceptible to vancomycin, although the methods by which this result was obtained were not stated.
Leuconostoc spp. are found on plants such as sugar cane, cabbage, and cucumber; they may be associated with milk and milk products and with wine production and related habitats. However, neither parent of the child examined in this study was that this organism was introduced prior to or during the preparation or packaging of the formula at the time of manufacture. Similarly, we did not recover Leuconostoc spp. from environmental samples taken from the formula preparation kitchen, but this bacterium could possibly have been introduced via the hands of hospital kitchen personnel.
We assume that the infection in the patient examined in this study began as colonization of the gastrostomy tube. While the patient may have developed bacteremia and bacteremic seeding of the central catheter from a gastric focus of infection, it is more likely that the organism was introduced externally from the gastrostomy through the Broviac catheter hub, which remained outside of the chest wall, since we demonstrated that the bacterium was present at this location.
Leuconostoc spp. have not been reported to be involved in human infections (11) . Their presence as colonizing organisms or transient members of the normal microbiota has also not been demonstrated (11) . Recently, Buu-Hoi et al. (5) have reported the recovery of nosocomially acquired, vancomycin-resistant streptococci or Leuconostoc spp. from the blood of two adult patients. The tests advocated by Garvie (9) (10) (11) to confirm the identity of the isolates as Leuconostoc were not performed, however. Shlaes et al. (11) , this difference may explain their intrinsic vancomycin resistance. While the isolates were susceptible to penicillin, and penicillin therapy combined with tobramycin was successful, the inability of penicillin to manifest its bactericidal effect may involve the same terminal amino acid structures. The bacteria had a MBC of penicillin that was commensurate with penicillin tolerance.
Results of this study indicate that the isolation of vancomycin-resistant-streptococci requires further investigation in the clinical laboratory. Our findings support the claims of Thornsberry and Facklam (Antimicrob. Newsl. 1:63-64, 1984) and underline the fact that Leuconostoc spp. may cause infections in humans, which is in contradiction to earlier statements (11) . With the increased use of vancomycin, clinicians and microbiologists must be aware of the potential complications caused by vancomycin-resistant bacteria, including Leuconostoc spp. The enzyme profile of Leuconostoc spp. suggests that this approach may prove useful in distinguishing these bacteria from other genera with overlapping phenotypic and morphological attributes.
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